It has also been used as a molecular marker for targeted therapies, such as chemokine receptor 7 (CXCR7) in BC [32], CXCR2 in breast cancer [33], and CXCR5 in prostate cancer [34]. The gene discussed is ACKR3; the disease is breast cancer.